Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxidative Deamination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107522763B reveals a high-yield route for Sofosbuvir intermediate VII, eliminating chromatography and reducing costs for pharmaceutical manufacturers.
Patent CN108912043B reveals a green synthesis method for 2,3,5-trichloropyridine, offering high yields and reduced waste for reliable agrochemical intermediate supply chains.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.